Cargando...
Molecular Mechanism of MART-1(+)/A*0201(+) Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor-CTL Interaction
Durable responses in metastatic melanoma patients remain generally difficult to achieve. Adoptive cell therapy with ex vivo engineered lymphocytes expressing high affinity T cell receptors TCRα/β for the melanoma antigen MART-1(27-35)/HLA A*0201 (recognized by F5 cytotoxic T lymphocytes [F5 CTLs]) h...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4180868/ https://ncbi.nlm.nih.gov/pubmed/21159666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1296 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|